Ginkgo Bioworks Hldgs Inc (DNA)
$0.28
0.02 (7.62%)
DNA Stock Quote Delayed 30 Minutes
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
Ginkgo Bioworks has multiple, positive catalysts that can make the low valuation of Ginkgo Bioworks stock melt up.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
38.33M
Day's Range
$0.28 - $0.31
52-Week Range
$0.26 - $2.54
Dividend & Yield
N/A (N/A)
DNA Stock Predictions, Articles, and Ginkgo Bioworks Hldgs Inc News
Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted
Ginkgo Bioworks stock is down, but this doesn't mean it's a bargain as Ginkgo Bioworks faces a serious delisting threat.
7 F-Rated Stocks To Sell in July
If you're going to outperform even a basic index fund this year, you need to identify any F-rated stocks to sell in July.
3 Biotech Stocks to Sell in July Before They Crash & Burn
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience.
Ginkgo Bioworks Layoffs Expand to 400 Job Cuts
Ginkgo Bioworks layoffs are coming for 400 of the company's employees as it seeks to reduce labor costs as part of a restructuring.
Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts
Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week.
5-Year Fortune Forecast: 3 Penny Stocks Destined for Massive Gains
Here are three Penny stocks to buy if you have the patience and risk tolerance to wait for a potential payoff.
7 Penny Stocks to Sell in June Before They Crash & Burn
It's way past time to dump these seven struggling penny stocks before things go from bad to worse for investors.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!
DNA Stock Earnings: Ginkgo Bioworks Holdings Meets EPS, Misses Revenue for Q1 2024
DNA stock results show that Ginkgo Bioworks Holdings met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
3 Meme Stocks to Sell in May Before They Crash & Burn
Traders have gravitated to meme stocks over the past year. But it's time to sell these three before the party ends.
Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock?
DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze.
3 Synthetic Biology Stocks Likely to Mint New Millionaires
Synthetic biology stocks are strongly worth considering for several reasons, particularly these three stocks.
